Evidence map›Paper›PMID 38179971›Full record

ArticlemBio2024

Intestinal

Courtney E Price, Rebecca A Valls, Alexis R Ramsey, Nicole A Loeven, Jane T Jones, Kaitlyn E Barrack, Joseph D Schwartzman, Darlene B Royce, Robert A Cramer, Juliette C Madan and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Characterization of gut microbiota in patients with diabetic kidney disease.Frontiers in cellular and infection microbiology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Courtney E Price *Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.ORCID 0000-0001-8003-2253
Rebecca A Valls *Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Alexis R RamseyDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Nicole A LoevenDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Jane T JonesDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Kaitlyn E BarrackDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Joseph D SchwartzmanDepartment of Pathology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Darlene B RoyceDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
Robert A CramerDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.ORCID 0000-0001-5503-5006
Juliette C MadanDepartment of Psychiatry, Geisel School of Medicine at Dartmouth, Hanove, USA.
Benjamin D RossDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.
James BliskaDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.ORCID 0000-0002-6047-8837
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, USA.ORCID 0000-0002-2861-4392
Dartmouth College · US

Funding

Translational Research CoreP30DK117469 · NIDDK · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 2018 to 2026
$13.9M
IMMUNOBIOLOGY OF MYELOID AND LYMPHOID CELLST32AI007363 · NIAID · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 1990 to 2026
$9.5M
Mechanisms of adaptation to interbacterial antagonism by the human gut microbiotaR35GM142685 · NIGMS · DARTMOUTH COLLEGE · PI ROSS, BENJAMIN DAVIDSON · 2021 to 2025
$2.0M
Dartmouth Cystic Fibrosis Training ProgramT32HL134598 · NHLBI · DARTMOUTH COLLEGE · PI George A. O'Toole · 2017 to 2026
$1.7M
Arsenic, the Microbiome & Health Outcomes: Mechanisms to Methods of InterventionR01ES033988 · NIEHS · DARTMOUTH COLLEGE · PI George A. O'Toole · 2023 to 2026
$1.6M
NHLBI NIH HHS T32 HL134598NIAID NIH HHS T32 AI007363NIDDK NIH HHS P30 DK117469NIEHS NIH HHS R01 ES033988NIGMS NIH HHS R35 GM142685
6 · The paper itself

Abstract

Persons with cystic fibrosis (CF), starting in early life, show intestinal microbiome dysbiosis characterized in part by a decreased relative abundance of the genus

Indexed as

Cystic FibrosisAnimalsBacteroidesCaco-2 CellsChildCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalDysbiosisEscherichia coliHumansInfantInflammationMicePropionatesCystic Fibrosis Transmembrane Conductance RegulatorPropionatescystic fibrosisgutinflammationprobioticpropionateSCFA

Identifiers

PMID38179971
PMCPMC10865972
OpenAlexW4390617450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.